Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

BACKGROUND: Receptor activator of nuclear factor κβ ligand (RANKL) has an important role in bone remodelling, and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) can induce apoptosis in cancer cells. Their functions are linked by their interactions with osteoprotegerin (OPG). OBJEC...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Cross, S S, Harrison, R F, Balasubramanian, S P, Lippitt, J M, Evans, C A, Reed, M W R, Holen, I
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2006
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860414/
https://ncbi.nlm.nih.gov/pubmed/16489180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.030031
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items